A detailed history of Commonwealth Equity Services, LLC transactions in Sc Pharmaceuticals Inc. stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 38,771 shares of SCPH stock, worth $135,698. This represents 0.0% of its overall portfolio holdings.

Number of Shares
38,771
Previous 36,771 5.44%
Holding current value
$135,698
Previous $160,000 10.63%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$4.12 - $5.51 $8,240 - $11,020
2,000 Added 5.44%
38,771 $177,000
Q2 2024

Jul 31, 2024

BUY
$3.51 - $5.21 $18,817 - $27,930
5,361 Added 17.07%
36,771 $160,000
Q4 2023

Feb 06, 2024

BUY
$4.7 - $6.63 $10,340 - $14,586
2,200 Added 7.53%
31,410 $197,000
Q4 2022

Feb 07, 2023

BUY
$4.02 - $7.53 $54,993 - $103,010
13,680 Added 88.09%
29,210 $209,000
Q2 2022

Jul 19, 2022

BUY
$4.3 - $6.48 $66,779 - $100,634
15,530 New
15,530 $74,000

Others Institutions Holding SCPH

About scPharmaceuticals Inc.


  • Ticker SCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,402,100
  • Market Cap $95.9M
  • Description
  • scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...
More about SCPH
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.